QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2022_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001335105')"}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 5,093,264
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 302,926
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,931,280
9 ResearchAndDevelopmentExpense 1,736,776
10 remainder_Expenses 2,059,803
11 remainder_Revenues 0
12 remainder_NetIncome -537
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,093,264
1 Liabilities 302,926
2 Expenses 6,727,859
3 Revenues 0
4 StockholdersEquity 4,790,338
5 NetIncome -6,728,396
6 ComprehensiveNetIncome -6,728,396
7 BaseVar 6,062,293
8 EconomicCapitalRatio 0.560

Edgar->Model Mapping

Feature Distribution

Change over Time